These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3293416)

  • 41. Prevalence of femoral atherosclerosis in asymptomatic men with hyperlipoproteinaemia.
    Ruhn G; Erikson U; Olsson AG
    J Intern Med; 1989 May; 225(5):317-23. PubMed ID: 2786545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Probucol (Lorelco) in treatment of hyperlipemia.
    Murphy BF
    JAMA; 1977 Dec; 238(23):2537-8. PubMed ID: 199758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits.
    Daugherty A; Zweifel BS; Schonfeld G
    Br J Pharmacol; 1989 Oct; 98(2):612-8. PubMed ID: 2819336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of probucol on low-density lipoproteins in patients resistant to diet therapy].
    Bertolami MC; Bertolami V
    Arq Bras Cardiol; 1982 Jun; 38(6):483-7. PubMed ID: 6762869
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of probucol on lipid metabolism and the clinical course of ischemic heart disease and arteriosclerosis obliterans of the vessels of the lower extremities].
    Dudaev VA; Gorin VV; Shingireĭ MV; Kliuchnikova ZhI; Diukov IV
    Kardiologiia; 1984 Jun; 24(6):76-9. PubMed ID: 6748497
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies of regression/progression of atherosclerosis in man.
    Blankenhorn DH
    Adv Exp Med Biol; 1977; 82():453-8. PubMed ID: 920402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Probucol, a new cholesterol lowering drug.
    Nash DT
    J Med; 1975; 6(5-6):305-15. PubMed ID: 768396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The additive effect of probucol on diet in hyperlipidemia.
    Brown HB; De Wolfe VG
    Clin Pharmacol Ther; 1974 Jul; 16(1):44-50. PubMed ID: 4602055
    [No Abstract]   [Full Text] [Related]  

  • 49. Tortuosity and atherosclerosis in the femoral artery: what is cause and what is effect?
    Smedby O; Bergstrand L
    Ann Biomed Eng; 1996; 24(4):474-80. PubMed ID: 8841722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of femoral atherosclerosis in relation to flow disturbances.
    Smedby O; Nilsson S; Bergstrand L
    J Biomech; 1996 Apr; 29(4):543-7. PubMed ID: 8964784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of probucol on lipid and lipoprotein levels and serum apolipoproteins A1 and B in patients with hyperlipoproteinemia type II].
    Sznajderman M; Zawadzki Z
    Kardiol Pol; 1985; 28(10):628-36. PubMed ID: 3938501
    [No Abstract]   [Full Text] [Related]  

  • 52. Changes in high-density lipoprotein subfraction distribution and increased cholesteryl ester transfer after probucol.
    Sirtori CR; Sirtori M; Calabresi L; Franceschini G
    Am J Cardiol; 1988 Jul; 62(3):73B-76B. PubMed ID: 3293417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Probucol and its mechanisms for reducing atherosclerosis.
    Jackson RL; Barnhart RL; Mao SJ
    Adv Exp Med Biol; 1991; 285():367-72. PubMed ID: 1858568
    [No Abstract]   [Full Text] [Related]  

  • 54. Predilection of atherosclerosis for the inner curvature in the femoral artery. A digitized angiography study.
    Smedby O; Johansson J; Mölgaard J; Olsson AG; Walldius G; Erikson U
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):912-7. PubMed ID: 7600123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Usefulness of probucol in treating primary hypercholesterolemia.
    Enjalbert M; Lussier-Cacan S; DuBreuil-Quidoz S; LeLorier J; Davignon J
    Can Med Assoc J; 1980 Oct; 123(8):754-7. PubMed ID: 7448680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A long-term (9 years) clinical study of the safety and efficacy of probucol, and an analysis of morbidity and mortality rates (author's transl)].
    Tedeschi RE; Martz BL; Taylor HA; Cerimelle BJ
    Nouv Presse Med; 1980 Oct; 9(40):3021-7. PubMed ID: 7003530
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The effects of probucol in man (author's transl)].
    Leutenegger M
    Nouv Presse Med; 1980 Oct; 9(40):2985-9. PubMed ID: 7443436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of familial and non-familial hypercholesterolaemia: a review of HMG-CoA reductase inhibitors and probucol.
    Tikkanen MJ; Helve E; Nikkilä EA
    Eur Heart J; 1987 Aug; 8 Suppl E():97-101. PubMed ID: 3315684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition by probucol of interleukin 1 secretion and its implication in atherosclerosis.
    Ku G; Doherty NS; Wolos JA; Jackson RL
    Am J Cardiol; 1988 Jul; 62(3):77B-81B. PubMed ID: 3260741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Computer-assisted femoral arteriography in serial assessment of atherosclerosis. A methodologic study.
    Nilsson S
    Acta Radiol Suppl; 1992; 378 ( Pt 3)():31-50. PubMed ID: 1323196
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.